Geht es tatsächlich um einen Kinder- und Kleinkinder-Tran, ein Haifischöl oder ein Schildkrötenöl?

While numerous studies and health authorities emphasize the risks associated with excessive fish consumption—primarily due to the accumulation of harmful substances such as dioxins and heavy metals (including mercury), whose detrimental effects on human health are well-documented—there are concurrently a multitude of scientifically validated benefits derived from incorporating fish and fish products into one’s diet. A viable alternative that mitigates these risks while preserving the advantageous properties is the use of high-quality pharmaceutical preparations. In clinically justified scenarios, targeted supplementation enables the delivery of essential nutrients without the necessity of consuming potentially contaminated fish meat. Particularly promising is the selective supplementation of those nutrients traditionally sourced from fish but whose intake is limited for safety reasons. Cod liver oil, a liquid fat extracted exclusively from the livers of gadiform fish—a family of marine species—represents one such solution. It should be distinguished from shark liver oil, which, despite certain similarities, is categorized as a distinct product. Although natural cod liver oil is characterized by a strong, often unpleasant taste, modern pharmaceutical advancements have led to the development of a wide array of flavored preparations that significantly enhance its palatability. The primary advantage of cod liver oil lies in its unique composition: a high concentration of polyunsaturated fatty acids from the omega-3 family (notably eicosapentaenoic acid – EPA and docosahexaenoic acid – DHA) alongside fat-soluble vitamins A, D, and E. It is worth noting that alpha-linolenic acid (ALA), also a member of the n-3 family, serves as a precursor for the synthesis of EPA and DHA. DHA and EPA exhibit a multifaceted range of health-promoting effects: they support neurological and cardiovascular functions, demonstrate anticancer potential, and contribute to the maintenance of optimal vision. Crucially, the human body is incapable of synthesizing these fatty acids in quantities sufficient to meet physiological demands, rendering their dietary supplementation indispensable.

Fish-derived oil, long regarded as a "cognitive and systemic health elixir", was as early as 1907 systematically prescribed in the United States to patients suffering from articular pathologies, spinal deformities (including rickets), advanced dental caries, visual acuity impairments, compromised immune responsiveness, and a spectrum of dermatological conditions. The foundation of its multifaceted efficacy lies in a distinctive biochemical profile: high-potency omega-3 polyunsaturated fatty acids (notably docosahexaenoic acid, DHA), retinol (vitamin A) – critical for ocular function and immune system modulation –, cholecalciferol (vitamin D3) – governing calcium-phosphate homeostasis, skeletal and dental mineralization –, and tocopherol (vitamin E), which serves a dual protective role: *in vitro* stabilization of polyunsaturated lipids against peroxidative degradation and *in vivo* scavenging of reactive oxygen species generated during metabolic stress. Extensive meta-analytical evidence demonstrates that therapeutic-dose ω-3 supplementation correlates with statistically significant reductions in premature mortality risk, malignant neoplasm development, primary hypertension, insulin resistance (a precursor to type 2 diabetes), while concurrently optimizing neurogenic and visual functions. Of particular note is DHA’s pivotal role in prenatal and early-childhood central nervous system development – longitudinal cohort studies reveal that children receiving adequate DHA doses within the first 24 months of life achieve markedly higher scores on standardized intelligence assessments. Equally critical is vitamin D, whose pleiotropic effects – ranging from gene expression regulation to inflammatory pathway modulation – position it as one of the body’s foremost homeostatic regulators.

Both breastfed infants and those receiving formula obtain essential polyunsaturated omega-3 fatty acids (including DHA and EPA) as well as vitamin D from diverse sources, the availability of which depends on the feeding method employed. During the initial months of life, the primary sources of these nutrients include breast milk—rich in bioactive compounds tailored to the developing nervous system—and high-quality infant formulas, which, in accordance with current nutritional guidelines, are fortified with targeted amounts of DHA. Following the completion of the sixth month, when complementary feeding begins, the introduction of long-chain omega-3 fatty acid sources becomes critical, such as fatty marine fish (e.g., salmon, mackerel, sardines) or—should their consumption prove insufficient—specially formulated fish oil supplements (such as cod liver oil) designed for infants. Current recommendations stipulate that children up to two years of age should receive a minimum of 100 milligrams of DHA daily, whereas older children (between 2 and 18 years) require a combined dose of 250 milligrams of EPA and DHA. Vitamin D supplementation, meanwhile, is advised from the earliest days of life regardless of feeding method, owing to its pivotal role in bone mineralization and immune response modulation.

Cod liver oil, derived from the liver of Atlantic cod (*Gadus morhua*), represents an exceptionally rich source of long-chain polyunsaturated omega-3 fatty acids—particularly docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA)—as well as fat-soluble vitamins, including cholecalciferol (D), retinol (A), and tocopherol (E). It serves as a valuable dietary supplement for infants (including those who are breastfed) and older children whose intake of marine fish and fish-derived products is insufficient to meet the required levels of these critical nutrients. In contrast, shark liver oil, though colloquially—and incorrectly—referred to as "tran" in some regions, contains lower concentrations of DHA, EPA, and vitamins A and D compared to cod liver oil. Its distinctive advantage, however, lies in its high content of bioactive compounds with well-documented immunomodulatory properties: alkylglycerols (notably 1-O-alkyl-*sn*-glycerol) and squalene. These substances enhance the activity of immune cells—such as granulocytes, B and T lymphocytes, and monocytes—by modulating intracellular signaling pathways and the expression of genes associated with immune responses. Both DHA/EPA and vitamin D play a foundational role in the psychomotor development of children, influencing cognitive function, motor skills, and neural maturation. Consistent supplementation—adhering to manufacturer guidelines or personalized pediatric recommendations—over a minimum of three months is necessary to observe beneficial health effects, including strengthened immune defense and support for neurological development.